ID
12793
Description
ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase; ODM derived from: https://clinicaltrials.gov/show/NCT00819351
Link
https://clinicaltrials.gov/show/NCT00819351
Keywords
Versions (1)
- 12/21/15 12/21/15 -
Uploaded on
December 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT00819351
Eligibility Acute Lymphoblastic Leukemia NCT00819351
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
bilineage all
Data type
boolean
Alias
- UMLS CUI [1]
- C0023464
Description
pre-treatment with glucocorticosteroids or other antileukemic agent
Data type
boolean
Alias
- UMLS CUI [1]
- C0149783
- UMLS CUI [2]
- C0596112
Description
cancer predisposition
Data type
boolean
Alias
- UMLS CUI [1]
- C2956961
Description
previous cancer
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
administration of additional chemotherapy during induction
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C1707479
Description
contraception
Data type
boolean
Alias
- UMLS CUI [1]
- C0700589
Description
allergic reactions to peg asparaginase
Data type
boolean
Alias
- UMLS CUI [1]
- C0020517
- UMLS CUI [2]
- C0071568
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00819351
- StudyEvent: Eligibility
C0596112 (UMLS CUI [2])
C1707479 (UMLS CUI [1,2])
C0071568 (UMLS CUI [2])